Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
This Bitcoin-first microcap is using its balance sheet to accumulate BTC (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Steep Hill Inc C.STPH

Healthcare Drug Manufacturers - Specialty & Generic
Steep Hill Inc. does not have significant operations. Previously, it operated as a cannabis-science company. The company was formerly known as Canbud Distribution Corp. and changed its name to Steep Hill Inc. in February 2022. The company was founded in 2008 and is based in Toronto, Canada.


CSE:STPH - Post by User

Steep Hill Inc
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(32)
•••
  • PindawgX
Post by Pindawgon Jan 08, 2021 8:03am
125 Views
Post# 32252150

Peers in Sector

Peers in SectorI have a feeling this will be doing some catch up very soon to its peers in the sector. Undervalued and ready to go. This will pop soon.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities